Sign In
Buy BEAM
$29.55
+0.590 (+2.04%)
At Close: Jun 03, 2026
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
08:54pm, Wednesday, 29'th Mar 2023
While it's a common conspiracy theory – and comedic punchline – that medical innovators only seek to manage problems rather than cure them, the reality is that several biotech stocks to buy underg
Beam Therapeutics to Participate in the Barclays 2023 Global Healthcare Conference
06:30am, Wednesday, 15'th Mar 2023
CAMBRIDGE, Mass., March 15, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that Gi
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
12:13pm, Monday, 06'th Mar 2023
The 2022 Nobel Prize in Chemistry went to Emmanuelle Charpentier and Jennifer Doudna for their work on developing tools to change the genetic code of living cells, tools called CRISPR/Cas. Yet long be
The Top 7 Growth Stocks in Biotech
06:57pm, Friday, 03'rd Mar 2023
Biotech stocks almost always have the potential for significant growth over time. Companies in the sector operate in areas including drug development, medical devices, and diagnostics.
Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Tops Revenue Estimates
09:02am, Tuesday, 28'th Feb 2023
Beam Therapeutics Inc. (BEAM) delivered earnings and revenue surprises of 59.09% and 69.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the sto
Beam Therapeutics: An Upgraded View
03:18pm, Thursday, 23'rd Feb 2023
Today, we are putting Beam Therapeutics back in the spotlight after an initial article on this gene editing name last summer. Beam Therapeutics' stock has sunk by a third since that avoid recommendati
Better Buy: Beam Therapeutics or Intellia Therapeutics?
06:00am, Wednesday, 22'nd Feb 2023
The two clinical-stage gene-editing companies have good long-term prospects.
7 CRISPR Stocks With the Best Long-Term Potential
07:10pm, Monday, 30'th Jan 2023
CRISPR technology has the potential to revolutionize the way we approach medicine. This technology has already been used in a variety of applications, including gene editing, gene therapy, and disease
5 Top Stocks for February
05:45am, Sunday, 29'th Jan 2023
These growth stocks have more room to run.
3 Great Growth Stocks Down 20% or More to Buy Now
09:37am, Friday, 27'th Jan 2023
These beaten-down stocks could be poised for major rebounds.
3 Stocks That Could Create Lasting Generational Wealth
05:50am, Sunday, 15'th Jan 2023
Making money that spans generations requires thinking big.
10 Potential 10x Return Stocks For The Next 10 Years
11:04am, Wednesday, 04'th Jan 2023
While others flock to safety, should you do the opposite? Some of the best times to invest in highly speculative names are when no one wants them, as long as the reasons are macro and not company or i
Beam Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
06:30am, Tuesday, 03'rd Jan 2023
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that man
3 Under-the-Radar Biotech Stocks to Buy in 2022
10:07am, Saturday, 24'th Dec 2022
The attraction of all three biotech stocks is their potential.
7 ‘Next Big Things' for Investors to Buy for 2023
01:16pm, Tuesday, 13'th Dec 2022
The next big things for investors are always around the corner. As investors say goodbye to the 2022 bear market, we look forward to what could be an excellent 2023.
